Kind of an ugly day, dow shed 113. The nasdaq declined 0. 15 i wont hammer you on the trade talks but highlight an opportunity that works regardless of how things play out with china for all we know the trade tussle could be with us for ages. I dont want you missing out on amazing opportunities that we see out here that arent bound by the narrow confines of the prc versus the United States so let me lay it all out for you. Thousands of companies are in trouble right now because they dont know how to deal with technology they dont understand the sales force or cybersecurity or pagerdutys always on mentality. If you want to compete having the right tech gives you an enormous edge. Thats the thesis that bind so many of them thats why target i think reported a blowout quarter, not just this morning and by the way a lot was Brian Cornell knowing how to use technology and kohls reported a hideous shortfall yesterday. Target has the right kind of tech kohls hasnt spent enough on it more later
Daré Bioscience, Inc (NASDAQ:DARE) Short Interest Update
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
Kane Biotech Announces First Quarter 2024 Financial Results
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Daré Bioscience (NASDAQ:DARE) Announces Earnings Results, Misses Expectations By $0 01 EPS
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright Reiterates Buy Rating for Daré Bioscience (NASDAQ:DARE)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.